TY - JOUR
T1 - Hearing Rehabilitation Implementing a Transcutaneous Bone Conduction Device
T2 - Single-Center Experience
AU - Shokri, Tom
AU - Czarnecki, Beth
AU - Baker, Aaron
AU - Isildak, Huseyin
N1 - Publisher Copyright:
© The Author(s) 2019.
PY - 2021/6
Y1 - 2021/6
N2 - Bone conduction implants based on percutaneous abutment acoustic transmission have been implemented in patients with satisfactory outcomes. However, adverse soft tissue outcomes present a limitation. Transcutaneous bone conduction devices (t-BCDs) are an alternative that may mitigate these complications. A retrospective review was performed of patients who underwent implantation of a t-BCD from 2013 to 2017. Surgical outcomes were reviewed including wound complications, frequency of device use, patient concerns regarding the device, and reported patient satisfaction. A total of 37 patients were implanted with the bone-anchored hearing aids, BAHA Attract (Cochlear™ Baha® Implant System). Average follow-up time was 271.8 days. Postoperatively, 7 (18.9%) patients complained of soft tissue changes or issues with wound healing. Twelve (32.4%) patients requested adjustment of their devices. The t-BCD is an excellent option for hearing rehabilitation. Overall, the complication rate is low, patient satisfaction is high, and successful conversion from a percutaneous device is possible with minimal risk.
AB - Bone conduction implants based on percutaneous abutment acoustic transmission have been implemented in patients with satisfactory outcomes. However, adverse soft tissue outcomes present a limitation. Transcutaneous bone conduction devices (t-BCDs) are an alternative that may mitigate these complications. A retrospective review was performed of patients who underwent implantation of a t-BCD from 2013 to 2017. Surgical outcomes were reviewed including wound complications, frequency of device use, patient concerns regarding the device, and reported patient satisfaction. A total of 37 patients were implanted with the bone-anchored hearing aids, BAHA Attract (Cochlear™ Baha® Implant System). Average follow-up time was 271.8 days. Postoperatively, 7 (18.9%) patients complained of soft tissue changes or issues with wound healing. Twelve (32.4%) patients requested adjustment of their devices. The t-BCD is an excellent option for hearing rehabilitation. Overall, the complication rate is low, patient satisfaction is high, and successful conversion from a percutaneous device is possible with minimal risk.
UR - http://www.scopus.com/inward/record.url?scp=85076575542&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076575542&partnerID=8YFLogxK
U2 - 10.1177/0145561319870481
DO - 10.1177/0145561319870481
M3 - Article
C2 - 31565979
AN - SCOPUS:85076575542
SN - 0145-5613
VL - 100
SP - 199S-203S
JO - Ear, Nose and Throat Journal
JF - Ear, Nose and Throat Journal
IS - 3_suppl
ER -